Effect of thiols on β2-adrenoceptors in human mononuclear leucocytes
- 23 Downloads
The effect of the disulfide reducing agent dithiothreitol (DTT) and other thiols on binding of the gb-adrenoceptor antagonist (−)-125iodocyanopindolol (125ICYP) to human mononuclear leucocytes (MNL) was investigated. Saturation experiments and dissociation kinetics revealed two classes of specific 125ICYP binding sites, one of high and the other of low affinity, respectively. In intact MNL DTT caused a decrease in specific binding. This was due almost selectively to a decrease in the affinity of high affinity binding sites, which decreased gradually in a concentration-dependent manner to the affinity of low affinity binding sites. In MNL membranes DTT decreased not only the affinity but also the number of high affinity binding sites. The DTT effect was completely reversible by simple reoxidation on air. The structural isomers (±)-DTT, (−)-DTT and dithioerythritol revealed identical effects on specific binding, whereas the monothiols mercaptoethanol and α-monothioglycerol, having a lower redox potential, were considerably less effective. In the same concentration range that influenced specific binding, DTT stimulated intracellular cAMP production. These results suggest functionally important disulfide bridges which regulate the affinity of β-adrenoceptor binding sites in human MNL. They stabilize the receptor in a high affinity state; their reduction causes the conversion of the high affinity state into a low affinity state in a process associated with stimulation of adenylate cyclase. Available evidence indicates that a similar transformation is made by β-adrenoceptor agonists. Consequently low affinity 125ICYP binding sites preexistent in untreated cells could represent a reduced receptor state resulting from agonist-receptor interaction in vivo.
Key wordsBeta-adrenoceptors Lymphocytes 125Iodo-cyanopindolol Adenosine cyclic monophosphate Dithiothreitol
Unable to display preview. Download preview PDF.
- Fitzgerald DJ, Doyle V, O'Brian ET, Kelly JG, O'Malley K (1983) Beta-adrenoceptor density and responsiveness in borderline hypertension. J Hypertension 1:260–262Google Scholar
- Haen E (1987) The peripheral lymphocyte as clinical model for receptor disturbances: asthmatic diseases. Bull Europ Respir 22:539–541Google Scholar
- Mahler HR, Cordes EH (1968) Basic biological chemistry. Harper and Row,NY, 24:346Google Scholar
- Pedersen SE, Ross EM (1986) Functional activation of β-adrenergic receptors by thiols in the presence and absence of agonists. J Biol Chem 260:14150–14157Google Scholar
- Remien J (1984) β-Adrenoceptor recognition sites in living lymphocytes: a model for receptor properties in human disease? Eur J Respir Dis 65 (135):208–214Google Scholar
- Vauquelin G, Bottari S, Kanarek L, Strosberg AD (1979) Evidence for essential disulfide bonds in β 1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. J Biol ] Chem 254:4462–4469Google Scholar
- Vauquelin G, Severne Y, Bottaxi S, Andre C (1984) Agonist-mediated conformational modification of β-adrenergic receptors. In: Liss AR (ed) Catecholamines: basic and peripheral mechanisms. Liss Inc., New York, pp 271–278Google Scholar